UPDATE: ESTIV2020 POSTPONED TO 2022!

Due to the COVID-19 pandemic and after lengthy and thoughtful deliberation, the ESTIV board has decided to postpone the 21st international congress of the European Society of Toxicology In Vitro (ESTIV2020), scheduled to take in Spain to 2022. The board also took into consideration the recent postponement of the World Congress on Alternatives from 2020 to 2021. The final dates will be communicated shortly through social media and other means.

This decision reflects public health concerns and acknowledges the severe restrictions in Spain now in place, especially for international travel. In addition, a number of organisations, hospitals and institutions have already instructed employees not to participate in international events, which will lead to a significant decrease in the number of participants, sponsors and speakers.

If you have submitted an abstract then these will be kept valid for the new date and your registration will be rolled over to the new date also. A frequently asked questions page on the congress website (https://estiv.org/estiv-2020-frequently-asked-questions/) provides further information about the postponement, how to transfer your registration or request a reimbursement. We are, of course, determined to maintain momentum, and will be taking steps to ensure continued progress on the new strategic plan and other initiatives.

We extend our best wishes to all participants, speakers and sponsors in this complex and challenging time. We regret not having the opportunity to see each of you in person this year, but look forward to gathering again in 2022 and in the meantime continuing our important work together.

Prof. Mathieu Vinken
ESTIV President